AtriCure (ATRC) Tops Q2 EPS by 22c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
AtriCure Inc. (ATRC) PT Raised to $30 at Northland Capital Markets
August 2, 2018 1:30 PM EDTNorthland Capital Markets raised its price target on AtriCure Inc. (NASDAQ: ATRC) to $30.00 (from $25.00) while maintaining an Outperform rating.
Analyst Suraj Kalia commented, "Atricure' Q2-18 revenues of $51.8M were roughly in-line with our estimate @ $50.8M. Appendage mgmt continues to be... More
AtriCure Inc. (ATRC) PT Raised to $36 at Needham & Company
August 2, 2018 6:31 AM EDTNeedham & Company raised its price target on AtriCure Inc. (NASDAQ: ATRC) to $36.00 (from $32.00) while maintaining a Buy rating.
Analyst Mike Matson commented, "ATRC's 2Q18 revenue accelerated to 13.5% vs. 12.0% in 1Q18 and beat consensus. Management raised its 2018 revenue guidance to $193-197M... More
